0
Skip to Content
Devah Therapeutics
About
Devah Therapeutics
About
About

Renewing Medicines. Restoring Lives.
Devah Therapeutics is advancing DTC-001, a non-sedating CNS therapy with 50+ years of international use, through the FDA 505(b)(2) pathway. Lead indication: tinnitus.

© 2026 Devah Therapeutics. All rights reserved.